Spruce Biosciences, Inc. (SPRB)
OTCMKTS
· Delayed Price · Currency is USD
0.0786
-0.0005 (-0.63%)
Apr 28, 2025, 4:00 PM EDT
Spruce Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 38.75 | 96.34 | 24.49 | 42.75 | 157.15 | Upgrade
|
| Short-Term Investments | - | - | 54.59 | 46.22 | - | Upgrade
|
| Cash & Short-Term Investments | 38.75 | 96.34 | 79.08 | 88.97 | 157.15 | Upgrade
|
| Cash Growth | -59.77% | 21.83% | -11.12% | -43.39% | 3904.84% | Upgrade
|
| Prepaid Expenses | 3.18 | 3.88 | 3.32 | 2.53 | 2.97 | Upgrade
|
| Restricted Cash | - | - | 0.22 | - | - | Upgrade
|
| Other Current Assets | 2.28 | 1.97 | 1 | 0.4 | 0.28 | Upgrade
|
| Total Current Assets | 44.21 | 102.18 | 83.61 | 91.9 | 160.4 | Upgrade
|
| Property, Plant & Equipment | 0.93 | 1.18 | 1.4 | 1.48 | 1.87 | Upgrade
|
| Long-Term Investments | - | - | - | 32.46 | - | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.58 | 0.64 | 0.65 | 0.62 | Upgrade
|
| Total Assets | 45.21 | 103.95 | 85.65 | 126.49 | 162.88 | Upgrade
|
| Accounts Payable | 1.3 | 3.33 | 1.43 | 2.82 | 3.63 | Upgrade
|
| Accrued Expenses | 12.05 | 14.35 | 9.26 | 5.69 | 3.33 | Upgrade
|
| Current Portion of Long-Term Debt | 1.62 | 1.62 | 1.62 | - | 2.55 | Upgrade
|
| Current Portion of Leases | 0.28 | 0.25 | 0.14 | 0.36 | 0.25 | Upgrade
|
| Current Unearned Revenue | - | 4.91 | - | - | - | Upgrade
|
| Total Current Liabilities | 15.25 | 24.47 | 12.45 | 8.87 | 9.76 | Upgrade
|
| Long-Term Debt | 0.12 | 1.72 | 3.29 | 4.88 | 1.92 | Upgrade
|
| Long-Term Leases | 0.74 | 1.02 | 1.26 | 1.29 | 1.65 | Upgrade
|
| Other Long-Term Liabilities | 0.28 | 0.24 | 0.16 | 0.07 | 0.12 | Upgrade
|
| Total Liabilities | 16.39 | 27.44 | 17.16 | 15.12 | 13.46 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 279.09 | 273.74 | 218.35 | 214.69 | 210.27 | Upgrade
|
| Retained Earnings | -250.27 | -197.23 | -149.31 | -103.13 | -60.84 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.56 | -0.18 | - | Upgrade
|
| Total Common Equity | 28.82 | 76.51 | 68.49 | 111.37 | 149.43 | Upgrade
|
| Shareholders' Equity | 28.82 | 76.51 | 68.49 | 111.37 | 149.43 | Upgrade
|
| Total Liabilities & Equity | 45.21 | 103.95 | 85.65 | 126.49 | 162.88 | Upgrade
|
| Total Debt | 2.77 | 4.61 | 6.32 | 6.53 | 6.38 | Upgrade
|
| Net Cash (Debt) | 35.99 | 91.73 | 72.76 | 82.44 | 150.77 | Upgrade
|
| Net Cash Growth | -60.77% | 26.07% | -11.74% | -45.32% | - | Upgrade
|
| Net Cash Per Share | 0.87 | 2.38 | 3.09 | 3.53 | 25.17 | Upgrade
|
| Filing Date Shares Outstanding | 42.23 | 41.15 | 39.75 | 23.49 | 23.3 | Upgrade
|
| Total Common Shares Outstanding | 42.23 | 41.03 | 23.6 | 23.49 | 23.26 | Upgrade
|
| Working Capital | 28.96 | 77.72 | 71.16 | 83.02 | 150.63 | Upgrade
|
| Book Value Per Share | 0.68 | 1.86 | 2.90 | 4.74 | 6.42 | Upgrade
|
| Tangible Book Value | 28.82 | 76.51 | 68.49 | 111.37 | 149.43 | Upgrade
|
| Tangible Book Value Per Share | 0.68 | 1.86 | 2.90 | 4.74 | 6.42 | Upgrade
|
| Machinery | - | - | - | - | 0.06 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.